SPOTLIGHT: Injunction issued against generic Plavix

Sanofi-Aventis and Bristol-Myers Squibb have won a round in their desperate fight to retain control of the blood thinner Plavix. A federal judge in New York issued a preliminary injunction against further sales of a copycat version of Plavix but refused their request for a recall of the generic supplies already shipped out. The judge will weigh arguments that Apotex improperly released a generic form of Plavix. Report

Suggested Articles

One day after its Opdivo-paired prospect flopped, Five Prime is farming out some preclinical antibodies to keep its clinical-stage pipeline alive.

Gilead has a new head of research biology: Michael Quigley, Ph.D., an alum of MedImmune, Janssen and Dana Farber, who joins from Bristol-Myers Squibb.

The back-to-back pivotal successes tee Incyte up to talk to regulators about bringing the JAK inhibitor to market.